|
| |
Image Results
Loading...
Loading...
PDL Biopharma Pages on BioPortfolio:
|
BioPortfolio Biotechnology BioNews : live article
Volociximab is being co-developed by PDL BioPharma and Biogen Idec. Interim results were presented from three, Phase 2, open-label clinical trials of ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - PDL BioPharma - Profile
View the current PDL BioPharma Page on BioPortfolio.com ... PDL BioPharma is a leader in the discovery, development and marketing of innovative therapies ...
http://www.bioportfolio.com/biocorporate/27960-PDL%2525252BB...
|
Biotechnology News SYNAGIS Search
28 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI - News) today reported financial results for the third quarter ended September 30, ...
http://www.bioportfolio.co.uk/SYNAGIS-news.htm...
|
BioPortfolio News: PDL BioPharma, Inc. - PDL BioPharma Announces ...
PDL BioPharma, Inc. - PDL BioPharma Announces Special... - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/news/PDL-BioPharma-Announces-Spe...
|
BioPortfolio - PDL BioPharma, Inc. - PDL BioPharma Announces ...
Read PDL BioPharma Announces Pricing of $300000000 Securitization ... NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL ...
http://www.bioportfolio.com/news/PDL-BioPharma-Announces-Pri...
|
BioPortfolio - Procyon BioPharma - Profile
third quarter of 2008 -- Non-GAAP income from operations(1) for the third quarter. PDL BioPharma ... $300 million securitization transaction. PDL
BioPharma ...
http://www.bioportfolio.com/biocorporate/8537-Procyon%252525...
|
BioPortfolio - AMBRILIA BIOPHARMA - Profile
28th October, 2009 PDL BioPharma, Inc. -- The failure of licensees to comply with existing license agreements, including any failure to pay royalties due.
...
http://www.bioportfolio.com/biocorporate/35395-AMBRILIA+BIOP...
| Results from other life science and pharmaceutical sites:
PDL BioPharma :
12 Nov 2009 ... Develops humanized monoclonals to prevent and treat autoimmune disease, inflammatory conditions, cancers and viral infections.
http://www.pdl.com/...
|
BioSpace - PDL BioPharma, Inc. News, Search Jobs, Events
PDL BioPharma, Inc. Headquarters and R&D 1400 Seaport Boulevard ... PDL BioPharma, Inc. (PDLI) Announces Closing of $300000000 Securitization
Transaction ...
http://www.biospace.com/company_profile.aspx?CompanyId=10011...
|
PDL BioPharma : About Us : Contact Information
PDL BioPharma · Management Board of Directors Corporate Governance News Releases ... Driving Directions · Terms of Use Contact Us ©2006 PDL BioPharma, Inc.
http://www.pdl.com/index.cfm?navId=24...
|
PDL BioPharma Inc. - Google Finance
Get the latest on PDL BioPharma Inc. including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=NASDAQ:PDLI...
|
PDL BioPharma : Content Unavailable
PDL BioPharma · Management Board of Directors Corporate Governance News ... Please check our Site Map. Terms of Use Contact Us ©2006 PDL BioPharma, Inc.
http://www.pdl.com/index.cfm?navId=37...
|
PDL BioPharma Announces Special Dividend Payment
PDL BioPharma Announces Special Dividend Payment. Record Date of December 1 and Payment Date of December 15 Set.
http://www.prnewswire.com/news-releases/pdl-biopharma-announ...
|
PDL BioPharma : About Us : Management
PDL BioPharma · Management Board of Directors Corporate Governance ... Karen Wilson Vice President of Finance. Terms of Use Contact Us ©2006 PDL BioPharma,
Inc.
http://www.pdl.com/index.cfm?navId=30...
|
DailyMed: About DailyMed
Cardene® is a registered trademark of PDL BioPharma, Inc. Marketed by: PDL Biopharma, Inc. ... Imprint Code, CARDENE;SR;30;mg;PDL;BioPharma, Coating, true
...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=7349...
|
PDL BioPharma : About Us
PDL BioPharma (PDL) pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments ...
http://www.pdl.com/index.cfm?navid=2...
|
PDL BioPharma Announces Closing of $300000000 Securitization ...
PDL BioPharma Announces Closing of $300000000 Securitization Transaction. ... NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of ...
http://www.prnewswire.com/news-releases/pdl-biopharma-announ...
|
|
